Integrated BioPharma, Inc. (OTCMKTS:INBP) Short Interest Up 23.1% in November

Integrated BioPharma, Inc. (OTCMKTS:INBP) saw a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 6,400 shares, an increase of 23.1% from the October 31st total of 5,200 shares. Based on an average daily volume of 13,900 shares, the days-to-cover ratio is currently 0.5 days.

Integrated BioPharma Price Performance

OTCMKTS INBP traded down $0.00 on Monday, hitting $0.32. 7,031 shares of the company’s stock were exchanged, compared to its average volume of 10,587. The firm has a market cap of $9.63 million, a price-to-earnings ratio of 16.00 and a beta of 0.62. The firm’s 50-day moving average price is $0.29 and its two-hundred day moving average price is $0.24. Integrated BioPharma has a fifty-two week low of $0.16 and a fifty-two week high of $0.35.

Integrated BioPharma (OTCMKTS:INBP) last issued its earnings results on Friday, September 20th. The company reported $0.01 earnings per share for the quarter. Integrated BioPharma had a net margin of 0.84% and a return on equity of 2.26%. The company had revenue of $12.75 million for the quarter.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.